1. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, et al. Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 2009; 92: 1586-1593. [
DOI:10.1016/j.fertnstert.2008.08.127]
2. Pe-arrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod 2005; 20; 915-922. [
DOI:10.1093/humrep/deh718]
3. Bukman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 2001; 7; 581-590. [
DOI:10.1093/humupd/7.6.581]
4. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti- Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003; 15; 211: 85-90. [
DOI:10.1016/j.mce.2003.09.024]
5. Van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002; 17: 3065-3071. [
DOI:10.1093/humrep/17.12.3065]
6. Van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004; 11: 601-606. [
DOI:10.1097/01.GME.0000123642.76105.6E]
7. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Carducci Artenisio A, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010; 16: 113-130. [
DOI:10.1093/humupd/dmp036]
8. Chu MC, Carmina E, Wang J, Lobo RA. Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertil Steril 2005; 84: 1685-1688. [
DOI:10.1016/j.fertnstert.2005.06.026]
9. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005; 20: 1820-1826. [
DOI:10.1093/humrep/deh850]
10. Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA. Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol 2007; 196: e1-5. [
DOI:10.1016/j.ajog.2006.07.046]
11. Laas A. Assessment of ovarian reserve,is there a role for ovarian biopsy? Hum Reprod 2001;16,1055-1057. [
DOI:10.1093/humrep/16.6.1055]
12. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Müllerian hormone versus small antral follicle count (2-6 mm). J Assist Reprod Genet 2009; 26:319-325. [
DOI:10.1007/s10815-009-9319-5]
13. Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S. Increased anti-mullerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril 2009; 94: 198-204. [
DOI:10.1016/j.fertnstert.2009.03.004]
14. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004; 82:1323-1329. [
DOI:10.1016/j.fertnstert.2004.03.061]
15. Barriere P, Freour T, Mirallie S, Jean M, Bach-Ngohou K, Masson D. Anti-mullerian hormone (AMH): Proposition of a cut-off in assisted reproductive therapy (ART) for a promising new marker (measured with Beckman Coulter ELISA). Fertil Steril 2006; 86: S289. [
DOI:10.1016/j.fertnstert.2006.07.773]
16. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 2006; 85:592-596. [
DOI:10.1016/j.fertnstert.2005.09.019]
17. Penarrubia J, Fabregues F, Manau D, Creus M, Casals G, Casamitjana R, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod 2005; 20: 915-922. [
DOI:10.1093/humrep/deh718]
18. Sills E, Alper M, Walsh A. Ovarian reserve screening in infertility: Practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol 2009; 146: 30-36. [
DOI:10.1016/j.ejogrb.2009.05.008]